USA Circulating Biomarker Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Circulating Biomarker market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Circulating Biomarker market. Detailed analysis of key players, along with key growth strategies adopted by Circulating Biomarker industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bio-Rad Laboratories (US)

    • Guardant Health (US)

    • MDxHealth SA (US)

    • Janssen Diagnostics (US)

    • Fraunhofer-Gesellschaft (Germany)

    • QIAGEN (Netherlands)

    • Biocept Inc (US)

    • Roche (Switzerland)

    • Trovagene (US)

    • Myriad Genetics (US)

    By Type:

    • Lung

    • Breast

    • Colorectal

    • Prostate

    By End-User:

    • Reference Laboratory

    • Research Centers

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Circulating Biomarker Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Circulating Biomarker Market Size and Growth Rate of Lung from 2016 to 2027

      • 1.3.2 USA Circulating Biomarker Market Size and Growth Rate of Breast from 2016 to 2027

      • 1.3.3 USA Circulating Biomarker Market Size and Growth Rate of Colorectal from 2016 to 2027

      • 1.3.4 USA Circulating Biomarker Market Size and Growth Rate of Prostate from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Circulating Biomarker Market Size and Growth Rate of Reference Laboratory from 2016 to 2027

      • 1.4.2 USA Circulating Biomarker Market Size and Growth Rate of Research Centers from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Circulating Biomarker Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Circulating Biomarker by Major Types

      • 3.4.1 Market Size and Growth Rate of Lung

      • 3.4.2 Market Size and Growth Rate of Breast

      • 3.4.3 Market Size and Growth Rate of Colorectal

      • 3.4.4 Market Size and Growth Rate of Prostate

    4 Segmentation of Circulating Biomarker Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Circulating Biomarker by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Circulating Biomarker in Reference Laboratory

      • 4.4.2 Market Size and Growth Rate of Circulating Biomarker in Research Centers

    5 Market Analysis by Regions

    • 5.1 USA Circulating Biomarker Production Analysis by Regions

    • 5.2 USA Circulating Biomarker Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Circulating Biomarker Landscape Analysis

    • 6.1 West USA Circulating Biomarker Landscape Analysis by Major Types

    • 6.2 West USA Circulating Biomarker Landscape Analysis by Major End-Users

    7 South USA Circulating Biomarker Landscape Analysis

    • 7.1 South USA Circulating Biomarker Landscape Analysis by Major Types

    • 7.2 South USA Circulating Biomarker Landscape Analysis by Major End-Users

    8 Middle West USA Circulating Biomarker Landscape Analysis

    • 8.1 Middle West USA Circulating Biomarker Landscape Analysis by Major Types

    • 8.2 Middle West USA Circulating Biomarker Landscape Analysis by Major End-Users

    9 Northeast USA Circulating Biomarker Landscape Analysis

    • 9.1 Northeast USA Circulating Biomarker Landscape Analysis by Major Types

    • 9.2 Northeast USA Circulating Biomarker Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Bio-Rad Laboratories (US)

        • 10.1.1 Bio-Rad Laboratories (US) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Guardant Health (US)

        • 10.2.1 Guardant Health (US) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 MDxHealth SA (US)

        • 10.3.1 MDxHealth SA (US) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Janssen Diagnostics (US)

        • 10.4.1 Janssen Diagnostics (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Fraunhofer-Gesellschaft (Germany)

        • 10.5.1 Fraunhofer-Gesellschaft (Germany) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 QIAGEN (Netherlands)

        • 10.6.1 QIAGEN (Netherlands) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Biocept Inc (US)

        • 10.7.1 Biocept Inc (US) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Roche (Switzerland)

        • 10.8.1 Roche (Switzerland) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Trovagene (US)

        • 10.9.1 Trovagene (US) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Myriad Genetics (US)

        • 10.10.1 Myriad Genetics (US) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Lung from 2016 to 2027

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Breast from 2016 to 2027

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Colorectal from 2016 to 2027

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Prostate from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Reference Laboratory from 2016 to 2027

    • Figure USA Circulating Biomarker Market Size and Growth Rate of Research Centers from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Circulating Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Circulating Biomarker Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Circulating Biomarker

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Circulating Biomarker by Different Types from 2016 to 2027

    • Table Consumption Share of Circulating Biomarker by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Lung

    • Figure Market Size and Growth Rate of Breast

    • Figure Market Size and Growth Rate of Colorectal

    • Figure Market Size and Growth Rate of Prostate

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Circulating Biomarker by Different End-Users from 2016 to 2027

    • Table Consumption Share of Circulating Biomarker by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Reference Laboratory

    • Figure Market Size and Growth Rate of Research Centers

    • Table USA Circulating Biomarker Production by Regions

    • Table USA Circulating Biomarker Production Share by Regions

    • Figure USA Circulating Biomarker Production Share by Regions in 2016

    • Figure USA Circulating Biomarker Production Share by Regions in 2021

    • Figure USA Circulating Biomarker Production Share by Regions in 2027

    • Table USA Circulating Biomarker Consumption by Regions

    • Table USA Circulating Biomarker Consumption Share by Regions

    • Figure USA Circulating Biomarker Consumption Share by Regions in 2016

    • Figure USA Circulating Biomarker Consumption Share by Regions in 2021

    • Figure USA Circulating Biomarker Consumption Share by Regions in 2027

    • Table West USA Circulating Biomarker Consumption by Types from 2016 to 2027

    • Table West USA Circulating Biomarker Consumption Share by Types from 2016 to 2027

    • Figure West USA Circulating Biomarker Consumption Share by Types in 2016

    • Figure West USA Circulating Biomarker Consumption Share by Types in 2021

    • Figure West USA Circulating Biomarker Consumption Share by Types in 2027

    • Table West USA Circulating Biomarker Consumption by End-Users from 2016 to 2027

    • Table West USA Circulating Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Circulating Biomarker Consumption Share by End-Users in 2016

    • Figure West USA Circulating Biomarker Consumption Share by End-Users in 2021

    • Figure West USA Circulating Biomarker Consumption Share by End-Users in 2027

    • Table South USA Circulating Biomarker Consumption by Types from 2016 to 2027

    • Table South USA Circulating Biomarker Consumption Share by Types from 2016 to 2027

    • Figure South USA Circulating Biomarker Consumption Share by Types in 2016

    • Figure South USA Circulating Biomarker Consumption Share by Types in 2021

    • Figure South USA Circulating Biomarker Consumption Share by Types in 2027

    • Table South USA Circulating Biomarker Consumption by End-Users from 2016 to 2027

    • Table South USA Circulating Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Circulating Biomarker Consumption Share by End-Users in 2016

    • Figure South USA Circulating Biomarker Consumption Share by End-Users in 2021

    • Figure South USA Circulating Biomarker Consumption Share by End-Users in 2027

    • Table Middle West USA Circulating Biomarker Consumption by Types from 2016 to 2027

    • Table Middle West USA Circulating Biomarker Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Circulating Biomarker Consumption Share by Types in 2016

    • Figure Middle West USA Circulating Biomarker Consumption Share by Types in 2021

    • Figure Middle West USA Circulating Biomarker Consumption Share by Types in 2027

    • Table Middle West USA Circulating Biomarker Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Circulating Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Circulating Biomarker Consumption Share by End-Users in 2016

    • Figure Middle West USA Circulating Biomarker Consumption Share by End-Users in 2021

    • Figure Middle West USA Circulating Biomarker Consumption Share by End-Users in 2027

    • Table Northeast USA Circulating Biomarker Consumption by Types from 2016 to 2027

    • Table Northeast USA Circulating Biomarker Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Circulating Biomarker Consumption Share by Types in 2016

    • Figure Northeast USA Circulating Biomarker Consumption Share by Types in 2021

    • Figure Northeast USA Circulating Biomarker Consumption Share by Types in 2027

    • Table Northeast USA Circulating Biomarker Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Circulating Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Circulating Biomarker Consumption Share by End-Users in 2016

    • Figure Northeast USA Circulating Biomarker Consumption Share by End-Users in 2021

    • Figure Northeast USA Circulating Biomarker Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Bio-Rad Laboratories (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories (US)

    • Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories (US)

    • Figure Revenue and Market Share Analysis of Bio-Rad Laboratories (US)

    • Table Product and Service Introduction of Bio-Rad Laboratories (US)

    • Table Company Profile and Development Status of Guardant Health (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guardant Health (US)

    • Figure Sales and Growth Rate Analysis of Guardant Health (US)

    • Figure Revenue and Market Share Analysis of Guardant Health (US)

    • Table Product and Service Introduction of Guardant Health (US)

    • Table Company Profile and Development Status of MDxHealth SA (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MDxHealth SA (US)

    • Figure Sales and Growth Rate Analysis of MDxHealth SA (US)

    • Figure Revenue and Market Share Analysis of MDxHealth SA (US)

    • Table Product and Service Introduction of MDxHealth SA (US)

    • Table Company Profile and Development Status of Janssen Diagnostics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Diagnostics (US)

    • Figure Sales and Growth Rate Analysis of Janssen Diagnostics (US)

    • Figure Revenue and Market Share Analysis of Janssen Diagnostics (US)

    • Table Product and Service Introduction of Janssen Diagnostics (US)

    • Table Company Profile and Development Status of Fraunhofer-Gesellschaft (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fraunhofer-Gesellschaft (Germany)

    • Figure Sales and Growth Rate Analysis of Fraunhofer-Gesellschaft (Germany)

    • Figure Revenue and Market Share Analysis of Fraunhofer-Gesellschaft (Germany)

    • Table Product and Service Introduction of Fraunhofer-Gesellschaft (Germany)

    • Table Company Profile and Development Status of QIAGEN (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN (Netherlands)

    • Figure Sales and Growth Rate Analysis of QIAGEN (Netherlands)

    • Figure Revenue and Market Share Analysis of QIAGEN (Netherlands)

    • Table Product and Service Introduction of QIAGEN (Netherlands)

    • Table Company Profile and Development Status of Biocept Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept Inc (US)

    • Figure Sales and Growth Rate Analysis of Biocept Inc (US)

    • Figure Revenue and Market Share Analysis of Biocept Inc (US)

    • Table Product and Service Introduction of Biocept Inc (US)

    • Table Company Profile and Development Status of Roche (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche (Switzerland)

    • Figure Sales and Growth Rate Analysis of Roche (Switzerland)

    • Figure Revenue and Market Share Analysis of Roche (Switzerland)

    • Table Product and Service Introduction of Roche (Switzerland)

    • Table Company Profile and Development Status of Trovagene (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trovagene (US)

    • Figure Sales and Growth Rate Analysis of Trovagene (US)

    • Figure Revenue and Market Share Analysis of Trovagene (US)

    • Table Product and Service Introduction of Trovagene (US)

    • Table Company Profile and Development Status of Myriad Genetics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics (US)

    • Figure Sales and Growth Rate Analysis of Myriad Genetics (US)

    • Figure Revenue and Market Share Analysis of Myriad Genetics (US)

    • Table Product and Service Introduction of Myriad Genetics (US)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.